๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Development of Rho-kinase inhibitors for cardiovascular medicine

โœ Scribed by Hiroaki Shimokawa; Mamunur Rashid

Book ID
116918717
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
650 KB
Volume
28
Category
Article
ISSN
0165-6147

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Development of specific Rho-kinase inhib
Development of specific Rho-kinase inhibitors and their clinical application
โœ Masahiro Tamura; Hiroshi Nakao; Hideo Yoshizaki; Masami Shiratsuchi; Hiromichi S ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 178 KB

Hexahydro-1-(isoquinoline-5-sulfonyl)-1H-1,4-diazepine, HA-1077, is a known selective inhibitor of Rho-kinase. Although its IC(50) value against Rho-kinase is more than 10 times lower than those for kinases such as PKA, PKB, PKC, PKG, MLCK, CaMKII and others, the molecule still retains relative pote

Kinase inhibitors for cardiovascular dis
Kinase inhibitors for cardiovascular disease
โœ Rajesh Kumar; Vivek P. Singh; Kenneth M. Baker ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 602 KB